Edition:
United Kingdom

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

3.00USD
15 Dec 2017
Change (% chg)

$-0.10 (-3.23%)
Prev Close
$3.10
Open
$3.10
Day's High
$3.10
Day's Low
$3.00
Volume
119,914
Avg. Vol
50,109
52-wk High
$4.20
52-wk Low
$2.45

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.34 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.33 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.50 0.50 0.50 0.80
Quarter Ending Mar-18 1 0.30 0.30 0.30 0.80
Year Ending Dec-17 2 1.64 1.90 1.39 2.00
Year Ending Dec-18 3 0.97 1.90 0.00 2.00
Earnings (per share)
Quarter Ending Dec-17 2 -0.34 -0.33 -0.36 -0.28
Quarter Ending Mar-18 2 -0.37 -0.36 -0.37 -0.30
Year Ending Dec-17 2 -1.31 -1.30 -1.32 -1.27
Year Ending Dec-18 3 -1.34 -1.25 -1.49 -1.30

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.40 0.46 0.06 15.75
Quarter Ending Jun-17 0.30 0.46 0.16 54.33
Quarter Ending Mar-17 0.80 0.46 0.34 42.25
Quarter Ending Dec-16 0.40 0.49 0.09 22.00
Quarter Ending Sep-16 0.40 0.40 0.00 1.25

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.50 0.50 0.50 0.40 0.80
Quarter Ending Mar-18 0.30 0.30 0.30 -- 0.80
Year Ending Dec-17 1.64 1.64 1.64 1.41 2.00
Year Ending Dec-18 0.97 0.97 0.97 0.97 2.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings